I have Type 1 diabetes. I love to write. I’m happy when I am helping others. I speak up when it’s important. I have a passion for sharing knowledge and learning new technology. I was BORN to BLOG!

I’ve met so many other T1Ds on this journey who are cool and love to help others. We put our heads and hearts together … to bring more resources and knowledge to our amazing diabetes community. We’re making improvements every day … come back often, let us know what you think. And my gratitude for my amazing webmaster, Dave (an honorary T1D)!

And thank you for stopping by!
— Joanne Laufer Milo, The Savvy Diabetic

Savvy Updates 7/1/24: Senseonics 365-day CGM, Dana Lewis on Exocrine Pancreatic Insufficiency, Apple/Fitbit/Garmin & Bacteria, Low-Dose SGLT2 Inhibitor May Protect Kidneys, Dual GLP-1 & Glucagon Agonist Pemvidutide, How GLP-1 Receptor Agonists Work

Savvy Updates 7/1/24: Senseonics 365-day CGM, Dana Lewis on Exocrine Pancreatic Insufficiency, Apple/Fitbit/Garmin & Bacteria, Low-Dose SGLT2 Inhibitor May Protect Kidneys, Dual GLP-1 & Glucagon Agonist Pemvidutide, How GLP-1 Receptor Agonists Work

Senseonics tips 365-day CGM to double 2025 sales by Nick Paul Taylor for MedTechDive.com, 25 June 2024. In 2024, Senseonics expects to more than double U.S. new patient starts and increase the global installed base by around 50%. The growth is built on the current...

read more
Savvy Updates 6/24/24:  Dex G7/Apple Watch Integration with Jake Leach, Off-limits T1D Meds (GLP-1 & SGLT-2), Sequel Twiist Improves Occlusion Detection, SGLT-2/GRA Good Combo for T1D, FDA Commissioner on What’s Wrong with Diabetes Technology, Precision Medicine with Diamyd, Tandem Appoints Kyrillos as COO, CKD Linked to Tooth Loss After Menopause, Amazon RxPass Program, PMBs Driving Up Drug Costs

Savvy Updates 6/24/24: Dex G7/Apple Watch Integration with Jake Leach, Off-limits T1D Meds (GLP-1 & SGLT-2), Sequel Twiist Improves Occlusion Detection, SGLT-2/GRA Good Combo for T1D, FDA Commissioner on What’s Wrong with Diabetes Technology, Precision Medicine with Diamyd, Tandem Appoints Kyrillos as COO, CKD Linked to Tooth Loss After Menopause, Amazon RxPass Program, PMBs Driving Up Drug Costs

Interview with Dexcom COO Jake Leach about the Dexcom G7/Apple Watch Integration by Daniel Trecroci for BeyondType1.org, June 2024. Explore the innovative pairing of the Apple Watch and the Dexcom G7 continuous glucose monitoring (CGM) device.  In this...

read more
Savvy Updates 6/17/24:  Abbott Lingo & Libre Rio, Oral Insulin, Sensulin Smart Insulin, Biomea Fusion on Clinical Hold, Hydration Hacks, CGM Insurance Coverage, Diabetes Products Putting Profits Over Patients

Savvy Updates 6/17/24: Abbott Lingo & Libre Rio, Oral Insulin, Sensulin Smart Insulin, Biomea Fusion on Clinical Hold, Hydration Hacks, CGM Insurance Coverage, Diabetes Products Putting Profits Over Patients

FDA approves Abbott’s Lingo and Libre Rio glucose monitoring systems by Archana Rani for MedicalDevice-Network.com, June 2024. The US Food and Drug Administration (FDA) has approved Abbott’s Lingo and Libre Rio over-the-counter continuous glucose monitoring (CGM)...

read more
Savvy Updates 6/10/24:  Breakthrough T1D, Dexcom G7 Direct to Apple Watch, Tandem Diabetes Extended Wear Insulin Infusion Set Clinical Trial, Glucotrack Implantable CGM, Eating Veggies Improves Glucose Tolerance, Xylitol Increases Heart Attack Risk, Concierge Medicine

Savvy Updates 6/10/24: Breakthrough T1D, Dexcom G7 Direct to Apple Watch, Tandem Diabetes Extended Wear Insulin Infusion Set Clinical Trial, Glucotrack Implantable CGM, Eating Veggies Improves Glucose Tolerance, Xylitol Increases Heart Attack Risk, Concierge Medicine

JDRF Rebrands as Breakthrough T1D to Accelerate Type 1 Research and Advocacy by Daniel Trecroci for BeyondType1.org, 4 June 2024. On June 4, 2024, the Juvenile Diabetes Research Foundation (JDRF) announced that Breakthrough T1D was the new name for the...

read more
Savvy Updates 6/3/24:  Modular Medical MODD1 Insulin Pump, JDRF is REBRANDING, Semaglutide May Change Brain Response to Sweets, TCOYD+diaTribe 2024 Diabetes Forum & Reception

Savvy Updates 6/3/24: Modular Medical MODD1 Insulin Pump, JDRF is REBRANDING, Semaglutide May Change Brain Response to Sweets, TCOYD+diaTribe 2024 Diabetes Forum & Reception

The Modular Medical MODD1 insulin pump. What do we know? by Tim Street for Diabettech.com, 31 May 2024. Modular Medical recently submitted their new pump system to the FDA for approval. It’s described as: "Effortless Insulin Delivery Made Possible."   The...

read more
Savvy Updates, 5/28/24: CamDiab Hybrid Closed Loop Approved, FDA Rejects Icodec, Ozempic Protects Kidneys, GLP-1 OK for Surgery, Physician Compensation Report 2024, Novo Nordisk Fires, Think Like a Pancreas: Is there a conspiracy?, Air Protein Solein, FIX Prior Authorizations

Savvy Updates, 5/28/24: CamDiab Hybrid Closed Loop Approved, FDA Rejects Icodec, Ozempic Protects Kidneys, GLP-1 OK for Surgery, Physician Compensation Report 2024, Novo Nordisk Fires, Think Like a Pancreas: Is there a conspiracy?, Air Protein Solein, FIX Prior Authorizations

FDA approves hybrid closed-loop insulin delivery app from CamDiab by Sean Whooley for DrugDelieveryBusiness.com, 24 May 2024. CamDiab announced today that the FDA granted authorization for its CamAPS FX advanced adaptive closed-loop artificial pancreas app. CamAPS FX,...

read more
Savvy Updates 5/20/24: Twiist Insulin Pump, FDA Alerts on Chinese Syringe Imports, Playing Sports Lowers Insulin Resistance, Insulin Sensitizers, Dr. Rayhan Lal on Automated Insulin Delivery Systems, ADA Lists Best Hospitals for T1Ds (ONLY 17 in the US!), CGMs & Insulin Pumps for T2D Market, Black Basta Cyberattacks on Healthcare Systems, Prior Auths Need to be Fixed

Savvy Updates 5/20/24: Twiist Insulin Pump, FDA Alerts on Chinese Syringe Imports, Playing Sports Lowers Insulin Resistance, Insulin Sensitizers, Dr. Rayhan Lal on Automated Insulin Delivery Systems, ADA Lists Best Hospitals for T1Ds (ONLY 17 in the US!), CGMs & Insulin Pumps for T2D Market, Black Basta Cyberattacks on Healthcare Systems, Prior Auths Need to be Fixed

Meet the newest insulin pump: all about “twiist” with Sequel CEO Alan Lotvin by Stacey Simms for Diabetes-Connections.com, 16 April 2024. This week, the newest pump coming to the market is called the twiist. It’s a very different shape – circular with a top half that...

read more
Savvy Updates, 5/13/2024: Tandem t:slim X2 App Recall, Novo Nordisk Drops Prices on GLP-1s, Xeris & Beta Bionics, Nanotech for Oral Insulin Delivery, Exocrine Pancreatic Insufficiency & T1D, Know Labs NI CGM & Machine Learning, Ascension Hacked, Stewart Health Files Chapter 11, On the Lighter Side – Parrots Prefer Live Video Calls!

Savvy Updates, 5/13/2024: Tandem t:slim X2 App Recall, Novo Nordisk Drops Prices on GLP-1s, Xeris & Beta Bionics, Nanotech for Oral Insulin Delivery, Exocrine Pancreatic Insufficiency & T1D, Know Labs NI CGM & Machine Learning, Ascension Hacked, Stewart Health Files Chapter 11, On the Lighter Side – Parrots Prefer Live Video Calls!

FDA Warns on (Tandem) Insulin Pump Problem by Kristen Monaco for MedPageToday.com, 8 May 2024. Mobile app glitch may cause t:slim X2 insulin pump battery to drain sooner than expected. A mobile app used with an insulin pump that led to 224 injuries was recalled...

read more
Savvy Updates, 5/6/24:  Eversense Authorized for Pump Integration, Walmart Health Shuts Down, Lilly Scales Up GLP-1 Production, Novo Prices Drop on GLP-1s, CVS Earnings Slashed, Neotame Sweetener Damages Gut, FTC Polices FDA’s Orange Book “Improper Listings”

Savvy Updates, 5/6/24: Eversense Authorized for Pump Integration, Walmart Health Shuts Down, Lilly Scales Up GLP-1 Production, Novo Prices Drop on GLP-1s, CVS Earnings Slashed, Neotame Sweetener Damages Gut, FTC Polices FDA’s Orange Book “Improper Listings”

Fully-implantable CGM receives FDA authorization for integration with insulin pumps by Jill Rollet for Healio.com/endocrinology, 30 April 2024. The Eversense E3 CGM (Senseonics Holdings and Ascensia Diabetes Care) received authorization to be marketed as an integrated...

read more
Savvy Updates, 4/29/24:  Cadisegliatin Regulates BG in Liver, Diabetes Driving Pal App, Female Physicians Result in Better Health Outcomes, UHC Data Breach “Substantial”, Pancreas Anatomy Image, Little Sleep Risky for T1D Teens, Vertex/TreeFrog Collab, Mounjaro/Zepbound Shortages, Ozempic in Denmark, Roasted Green Tea (houjicha)

Savvy Updates, 4/29/24: Cadisegliatin Regulates BG in Liver, Diabetes Driving Pal App, Female Physicians Result in Better Health Outcomes, UHC Data Breach “Substantial”, Pancreas Anatomy Image, Little Sleep Risky for T1D Teens, Vertex/TreeFrog Collab, Mounjaro/Zepbound Shortages, Ozempic in Denmark, Roasted Green Tea (houjicha)

Introducing Cadisegliatin, a New Drug in the Type 1 Diabetes Pipeline by Ross Wollen for DiabetesDaily.com, 26 April 2024. Cadisegliatin, an investigative therapy currently entering phase 3 trials, could be the next important drug, after insulin, indicated for Type 1...

read more
Share This
Skip to content